PRESS RELEASES

Contacts: Marc R. Viscogliosi, Viscogliosi Bros, LLC, (212) 583-9700 ext. 103
Nick Kilsby, Creative Partners PR, (203) 705-9202

SCIENTIST’S DISCOVERY OF CRITICAL ROLE OF AQUAPORIN, A MEMBRANE PROTEIN, IN SPINAL INJURIES RECOGNIZED WITH RESEARCH FUNDING AWARD FROM VISCOGLIOSI BROS. LLC

• Erica Nader Award goes to Dr. Olivera Nesic-Taylor of University of Texas, Galveston
• American Spinal Injury Association’s ‘Breakthrough Research’ choice at group’s 33rd Annual Scientific meeting in Tampa
• Marc Viscogliosi cites progress in regenerating spinal tissue

TAMPA, FLORIDA- June 1, 2007 - Dr. Olivera Nesic-Taylor, an assistant professor in biochemistry and molecular biology at the University of Texas, Galveston, was today presented with The Erica Nader Award for ‘breakthrough research in spinal cord regeneration.’

“Dr. Nesic-Taylor’s work in isolating proteins, such as aquaporin, that act to prevent tissue regeneration following spinal cord injury, represents a major leap forward in our understanding of a problem that has long plagued orthopedic and neurological specialists,” said Marc R. Viscogliosi, a principal of Viscogliosi Bros. LLC., a New York investment firm that conceived and has been funding the award since 2004.

Mr. Viscogliosi was addressing the 33rd Annual Scientific Meeting of the American Spinal Injury Association (ASIA) today in Tampa, Fl. The $10,000 research grant that comes with the award is the largest of several awards administered by ASIA. It is named after Ms. Nader who sustained a critical spinal injury in a 2001 auto accident and has since become a major figure in advocating and supporting the type of research cited in the award criteria.

Dr. Marcalee Sipski Alexander, President & Director of ASIA, said: “Dr. Nesic-Taylor is an outstanding young scientist in the field of nerve regeneration research. Her discoveries could lead to development of treatments capable of neutralizing or inhibiting the affect of proteins that allow onset of edema and syringomelia and other conditions associated with paraplegia.”

The inaugural winner of the Erica Nader Award, in 2004, was Ping Wu, Ph.D., Assistant Professor of Anatomy and Neuroscience at the University of Texas at Galveston. Dr. Wu’s work led to breakthrough stem cell research in spinal cord nerve cells.

In 2005, Damien Pearse, Ph.D., won for his work in the field of nerve regeneration research into myelin-associated inhibitors of axonal regeneration in the adult mammalian CNS. He was then an Assistant Professor in the Department of Neurological Surgery: Project to Cure Paralysis at The University of Miami Miller School of Medicine.

Dr. Stephen Davies, a spinal cord injury scientist at Baylor College of Medicine in Houston, TX, received the Eric Nader Award last year for his work on decorin, a molecule that has been shown to reduce the formation of scar tissue at the site of injury and promote nerve fiber growth and repair in the spinal cords of rats.

This year’s recipient, Dr. Nesic-Taylor, has presented her work in more than 40 medical forums, including the Christopher Reeve Paralysis Foundation and has become an authority on spinal cord injury. She has recently been invited to serve on the scientific advisory panel of the Spinal Cord Injury Research Foundation (for ‘paralyzed veterans’).

About Viscogliosi Bros., LLC
Established by Marc R. Viscogliosi, John J. Viscogliosi and Anthony G. Viscogliosi in New York City in 1999, Viscogliosi Bros., LLC (VB) was the first venture capital/private equity and merchant banking firm dedicated to the musculoskeletal/orthopedics sector of the health care industry.
 
Today, VB is a leading independent firm with a mission to create, build and finance companies founded on innovations developed by surgeons and uniquely focused on "life changing" musculoskeletal/orthopedic technologies. VB has worldwide surgeon, industry and trade relationships and significant financial expertise in the musculoskeletal/orthopedic sector.

As principals of VB, the Viscogliosi brothers have a combined total of nearly half a century of experience analyzing and investing in the musculoskeletal/orthopedics sector, directing literally billions of dollars through the orthopedics industry.  They have pioneered innovative financial, strategic and management initiatives for nearly 150 companies in the sector, from start-up, seed and development stage all the way to exit, while helping thousands of people lead better lives through the orthopedic and spinal products marketed and sold by the companies they have assisted in developing and financing.


> Back to Press Releases